Will Ashworth

Will Ashworth

InvestorPlace Contributor

Expertise: Public and private companies, Portfolio construction

About Will:
Will Ashworth has written about investments full-time since 2008. He loves investing and is passionate about helping others put their money to work. He particularly enjoys creating model portfolios that stand the test of time.

Publications where he’s appeared include InvestorPlace, The Motley Fool Canada, Investopedia, Kiplinger, and several others in both the U.S. and Canada. He lives in Halifax, Nova Scotia.

You can follow Will on LinkedIn. 

Recent Articles

AstraZeneca’s Loss is Amarin’s Big Gain This Year

By Will Ashworth, InvestorPlace Contributor

AstraZeneca is stopping a large clinical study of its fish-oil-derived heart drug, Epanova. That’s good news for Amarin and Amarin stock.

Can The Trade Desk Stock Reach $1,285 in 40 Months?

By Will Ashworth, InvestorPlace Contributor

TTD is benefiting from multiple, positive trends. As a result, TTD stock can continue to soar over the next few years, making the shares a smart buy at this point.

It’s Doubtful GE Stock Repeats Its Strong 2019 Performance

By Will Ashworth, InvestorPlace Contributor

While there’s no question GE stock has a lot of momentum on its side, is General Electric’s business strong enough to warrant a second consecutive year of outsize gains?

10 Mid-Cap ETFs to Buy for Next Decade

By Will Ashworth, InvestorPlace Contributor

The ETF has grown its total net assets to $1.6 billion in less than five years, a reasonably quick run to the billion-dollar mark. Unlike most passive ETFs that rebalance quarterly, JHMM is reconstituted and rebalanced semi-annually.

Does Infosys Have What It Takes to Reach $20?

By Will Ashworth, InvestorPlace Contributor

Infosys reported third-quarter results on Jan. 10. It's continuing its transformation, but is it enough for INFY stock to get to $20?

Load More